A common diabetes drug may help slow age-related vision loss, giving researchers a promising new clue for protecting eyesight ...
The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.
An international study found that finerenone slows kidney function decline and reduces the risk of serious kidney and ...
Health insurance covers the high costs of diabetes, such as a hospital stay for a serious complication, but not the daily costs of medicines and tests.
As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, ...
PvPI urges public for timely reporting of ADRs to strengthen safety monitoring of diabetes drug semaglutide: Shardul Nautiyal, Mumbai Monday, July 20, 2026, 08:00 Hrs [IST] Recogn ...
Beth Motley, a primary care physician specializing in family and lifestyle medicine, knows sharing a difficult journey can make all the difference ...
MedPage Today on MSN
Study Dampens Hope for GLP-1s as Insulin Off-Ramp in Type 2 Diabetes
No difference in insulin discontinuation rates seen among three glucose-lowering classes ...
Morning Overview on MSN
A common diabetes drug is showing signs of slowing aging in people
Metformin, a drug prescribed to tens of millions of people with type 2 diabetes, is producing measurable shifts in molecular ...
By Andrew Silver SHANGHAI, July 9 (Reuters) - China will add a second GLP-1 drug, used to treat diabetes, to a list of ...
Boehringer Ingelheim’s top-selling drug lifted sales in the first half, as the German drugmaker gears up to file for U.S.
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results